Skye Bioscience terminates RoseRyan; Principal Accounting Officer Janney resigns

Skye Bioscience, Inc.

Terminated RoseRyan engagement as of Sept 14, 2021; Richard Janney resigned as Principal Accounting Officer.
CEO Punit Dhillon will serve as principal accounting officer until successor is appointed.
Company moved to new office at 11250 El Camino Real, San Diego, leasing approx. 2,645 sq ft from ROIC California.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Janney

Principal Accounting Officer

SKYE · Skye Bioscience, Inc.

Effective: 2021-09-14
Successor: Punit Dhillon
Filed: September 15, 2021, 7:59 PM ET

As such, Richard Janney, the Company's Principal Accounting Officer engaged through RoseRyan, has tendered his resignation with the Company.

Role change (interim)

Punit Dhillon

Principal Accounting Officer

SKYE · Skye Bioscience, Inc.

Effective: 2021-09-14
Filed: September 15, 2021, 7:59 PM ET

Punit Dhillon, Chief Executive Officer, President, Secretary, Chair of the Board, and Director of the Company, will serve as the principal accounting officer until a successor is appointed.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Janney resigned as Principal Accounting Officer at Skye Bioscience, Inc..

Action: resigned
Role: Principal Accounting Officer

Exact text from the filing

As such, Richard Janney, the Company's Principal Accounting Officer engaged through RoseRyan, has tendered his resignation with the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Punit Dhillon changed role as Principal Accounting Officer at Skye Bioscience, Inc..

Action: will serve as
Role: Principal Accounting Officer

Exact text from the filing

Punit Dhillon, Chief Executive Officer, President, Secretary, Chair of the Board, and Director of the Company, will serve as the principal accounting officer until a successor is appointed.

View on SEC.gov

Skye Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-21-018623

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.